Michael Pergine is the policy and government lead for human health commercial at Merck. As such, he is responsible for industrial and healthcare policy and government relations efforts (IP protection, ...
With Keytruda’s market exclusivity running out, Merck is searching for ways to sustain revenue from the world’s top-selling drug, which recorded nearly $22 billion in sales through the first nine ...